Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 10;36(6):681-685.
doi: 10.2116/analsci.19P359. Epub 2019 Dec 13.

A Fluorescent Sensor Based on Reversible Addition-Fragmentation Chain Transfer Polymerization for the Early Diagnosis of Non-small Cell Lung Cancer

Affiliations
Free article

A Fluorescent Sensor Based on Reversible Addition-Fragmentation Chain Transfer Polymerization for the Early Diagnosis of Non-small Cell Lung Cancer

Wenwen Liu et al. Anal Sci. .
Free article

Abstract

We propose a novel, ultrasensitive and low-cost sensor using reversible addition-fragmentation chain transfer (RAFT) polymerization as a signal amplification strategy for the detection of CYFRA 21-1 DNA fragment, a tumor marker of non-small cell lung carcinoma. The peptide nucleic acid (PNA) probes were firstly immobilized on magnetic beads (MBs) to capture the CYFRA 21-1 DNA specifically. After hybridization, CPAD was tethered to the hetero duplexes through carboxylate-Zr4+-phosphate chemistry. Subsequently, a number of fluorescent tags were introduced to the heteroduplexes through RAFT polymerization, leading to an amplification of the fluorescence signal. The sensor demonstrates a low limit of detection (LOD) of 0.02 fM. It has great selectivity with respect to base mismatch DNA, and high anti-interference ability in normal human serum. Overall findings of the study suggest that proposed sensor holds enormous potential to be used as a tool for the early-stage diagnosis of lung cancers.

Keywords: CYFRA 21-1 DNA; RAFT; fluorescence; non-small cell lung carcinomas.

PubMed Disclaimer

References

    1. S. Cedres, I. Nunez, M. Longo, P. Martinez, E. Checa, D. Torrejon, and E. Felip, Clin. Lung Cancer, 2011, 12, 172. - DOI - PubMed
    1. J. E. Tota, A. V. Ramanakumar, and E. L. Franco, Lung, 2014, 192, 55. - DOI - PubMed
    1. H. D. Sikes, R. R. Hansen, L. M. Johnson, R. Jenison, J. W. Birks, K. L. Rowlen, and C. N. Bowman, Nat. Mater., 2008, 7, 52. - DOI - PubMed
    1. V. Denes, M. Lakk, A. Makarovskiy, P. Jakso, S. Szappanos, and L. Graf, Int. J. Cancer, 2015, 136, 1528. - DOI - PubMed
    1. Y. Li, Y. Pan, R. Wang, Y. Sun, H. Hu, and X. Shen, PLoS One, 2013, 8, e69016. - DOI - PubMed - PMC

MeSH terms